Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine

Vaccine

Volumn 26, Issue 16, 2008, Pages 1990-1998

  Co, Mary Dawn T ^a   Orphin, Laura ^a   Cruz, John ^a   Pazoles, Pamela ^a   Rothman, Alan L ^a   Ennis, Francis A ^a   Terajima, Masanori ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

B cells; Influenza; T cells

Indexed keywords

GAMMA INTERFERON; INACTIVATED VACCINE; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; TRIPLE VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFLUENZA VACCINATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, CD45; ANTIGENS, CD8; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON TYPE II; LYMPHOCYTE COUNT; MALE; NEUTRALIZATION TESTS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES; VACCINATION;

EID: 40849087614     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.02.024     Document Type: Article

References (40)

1. Harper S.A., Fukuda K., Uyeki T.M., Cox N.J., and Bridges C.B. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 53 May (RR-6) (2004) 1-40
2. Hilleman M.R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20 August (25-26) (2002) 3068-3087
3. Belshe R.B., and Gruber W.C. Safety efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. Philos Trans R Soc Lond B Biol Sci 356 December (1416) (2001) 1947-1951
4. Yamada A., Young J.F., and Ennis F.A. Influenza virus subtype-specific cytotoxic T lymphocytes lyse target cells coated with a protein produced in E. coli. J Exp Med 162 November (5) (1985) 1720-1725
5. Yamada Y.K., Meager A., Yamada A., and Ennis F.A. Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. J Gen Virol 67 November (Pt 11) (1986) 2325-2334
6. Askonas B.A., and Lin Y.L. An influenza specific T-killer clone is restricted to H-2Ld and cross-reacts with Dk region. Immunogenetics 16 1 (1982) 83-87
7. Kuwano K., Scott M., Young J.F., and Ennis F.A. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. J Immunol 140 February (4) (1988) 1264-1268
8. Kuwano K., Tamura M., and Ennis F.A. Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone. Virology 178 September (1) (1990) 174-179
9. Kuwano K., Braciale T.J., and Ennis F.A. Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Viral Immunol 2 Fall (3) (1989) 163-173
10. Bender B.S., Croghan T., Zhang L., and Small Jr. P.A. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175 April (4) (1992) 1143-1145
11. Graham M.B., and Braciale T.J. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med 186 December (12) (1997) 2063-2068
12. Epstein S.L., Lo C.Y., Misplon J.A., and Bennink J.R. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol 160 January (1) (1998) 322-327
13. Mackenzie C.D., Taylor P.M., and Askonas B.A. Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells. Immunology 67 July (3) (1989) 375-381
14. Wells M.A., Albrecht P., and Ennis F.A. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J Immunol 126 March (3) (1981) 1036-1041
15. Eichelberger M., Allan W., Zijlstra M., Jaenisch R., and Doherty P.C. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med 174 October (4) (1991) 875-880
16. Belz G.T., Wodarz D., Diaz G., Nowak M.A., and Doherty P.C. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 76 December (23) (2002) 12388-12393
17. Thomas P.G., Keating R., Hulse-Post D.J., and Doherty P.C. Cell-mediated protection in influenza infection. Emerg Infect Dis 12 January (1) (2006) 48-54
18. Ennis F.A., Rook A.H., Qi Y.H., Schild G.C., Riley D., Pratt R., et al. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet 2 October (8252) (1981) 887-891
19. Jameson J., Cruz J., and Ennis F.A. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol 72 November (11) (1998) 8682-8689
20. Jameson J., Cruz J., Terajima M., and Ennis F.A. Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol 162 June (12) (1999) 7578-7583
21. Boyam A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 Suppl. (1968) 77
22. Ennis F.A., Cruz J., Demkowicz Jr. W.E., Rothman A.L., and McClain D.J. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. J Infect Dis 185 June (11) (2002) 1657-1659
23. Currier J.R., Kuta E.G., Turk E., Earhart L.B., Loomis-Price L., Janetzki S., et al. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods 260 February (1-2) (2002) 157-172
24. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37 April (4) (1999) 937-943
25. Sasaki S., Jaimes M.C., Holmes T.H., Dekker C.L., Mahmood K., Kemble G.W., et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81 January (1) (2007) 215-228
26. Gross P.A., Ennis F.A., Gaerlan P.F., Denson L.J., Denning C.R., and Schiffman D. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis 136 November (5) (1977) 623-632
27. Rastogi S., Gross P.A., Bonelli J., Dran S., Levandowski R.A., Russo C., et al. Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol 2 January (1) (1995) 120-121
28. Gillespie G.M., Wills M.R., Appay V., O'Callaghan C., Murphy M., Smith N., et al. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol 74 September (17) (2000) 8140-8150
29. Wills M.R., Carmichael A.J., Weekes M.P., Mynard K., Okecha G., Hicks R., et al. Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J Immunol 162 June (12) (1999) 7080-7087
30. Arlettaz L., Barbey C., Dumont-Girard F., Helg C., Chapuis B., Roux E., et al. CD45 isoform phenotypes of human T cells: CD4(+)CD45RA(-)RO(+) memory T cells re-acquire CD45RA without losing CD45RO. Eur J Immunol 29 December (12) (1999) 3987-3994
31. Catalina M.D., Sullivan J.L., Brody R.M., and Luzuriaga K. Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells. J Immunol 168 April (8) (2002) 4184-4191
32. Durando P., Fenoglio D., Boschini A., Ansaldi F., Icardi G., Sticchi L., et al. Safety and immunogenicity of two influenza subunit vaccines, with or without MF59 adjuvant, administered to HIV-1 seropositive and seronegative adults. Clin Vaccine Immunol November (2007)
33. Long B.R., Michaelsson J., Loo C.P., Ballan W.M., Vu B.A., Hecht F.M., et al. Elevated frequency of IFN-{gamma} producing NK cells following Influenza vaccination in healthy adults. Clin Vaccine Immunol November (2007)
34. He X.S., Holmes T.H., Zhang C., Mahmood K., Kemble G.W., Lewis D.B., et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80 December (23) (2006) 11756-11766
35. Mbawuike I., Zang Y., and Couch R.B. Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant. Vaccine 25 April (17) (2007) 3263-3269
36. Rastogi D., Wang C., Mao X., Lendor C., Rothman P.B., and Miller R.L. Antigen-specific immune responses to influenza vaccine in utero. J Clin Invest 117 June (6) (2007) 1637-1646
37. Garcia-Canas V., Lorbetskie B., Bertrand D., Cyr T.D., and Girard M. Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection. Anal Chem 79 April (8) (2007) 3164-3172
38. McElhaney J.E., Hooton J.W., Hooton N., and Bleackley R.C. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 23 May (25) (2005) 3294-3300
39. Deng Y., Jing Y., Campbell A.E., and Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 172 March (6) (2004) 3437-3446
40. McElhaney J.E., Upshaw C.M., Hooton J.W., Lechelt K.E., and Meneilly G.S. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 16 November (18) (1998) 1742-1747